FCF Margin % is calculated as Free Cash Flow divided by its Revenue. LENSAR's Free Cash Flow for the
three
months ended in Dec. 2023 was $-0.53 Mil. LENSAR's Revenue for the
three
months ended in Dec. 2023 was $12.11 Mil. Therefore, LENSAR's FCF Margin % for the quarter that ended in Dec. 2023 was -4.34%.
The historical rank and industry rank for LENSAR's FCF Margin % or its related term are showing as below:
LNSR'
s FCF Margin % Range Over the Past 10 Years
Min: -53.66 Med: -42.34 Max: -23.47
Current: -23.47
During the past 5 years, the highest FCF Margin % of LENSAR was -23.47%. The lowest was -53.66%. And the median was -42.34%.
LNSR's FCF Margin % is ranked worse than 62.42% of 825
companies
in the Medical Devices & Instruments industry
Industry Median: -7.12
vs LNSR: -23.47
LENSAR FCF Margin % Historical Data
The historical data trend for LENSAR's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, LENSAR's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LENSAR's FCF Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LENSAR's FCF Margin % distribution charts can be found below:
* The bar in red indicates where LENSAR's FCF Margin % falls into.
LENSAR FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
LENSAR's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LENSAR FCF Margin % Related Terms
Thank you for viewing the detailed overview of LENSAR's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LNSR has been successfully added to your 